Impacting care in oncology

Informed choices

Precise decisions.

Свържете се с нас

Информация за контакт

* Това поле е задължително

Държава

Име*

Име (фонетичен)

Фамилия*

Фамилия (фонетичен)

Обръщение

Научно звание

Имейл адрес*

Телефон

Компания*

Длъжност

промишленост

Длъжност

специалност

Отдел

Щат / провинция

Град

Адрес

Пощенски код

Предишен

Като уточним причината Ви за връзка, ще можем да Ви предоставим по-добро обслужване.

Информация за проследяване

Предпочитан метод за контакт

Най-добро време за обаждане

Очаквано време за покупка

Коментиране

What is cross border data transfer?

I agree on cross-border transfer of personal information.

Бих искал да получавам рекламни електронни съобщения относно продукти на Philips, услуги, събития и промоции, които съответстват на моите потребителски предпочитания и поведение.

Предишен

February 4th is World Cancer Day

See what Philips was up to:

How close is the Cancer Moonshot to becoming reality?

Read the expert opinion on Philips Innovation matters blog

Follow Philips oncology on Linkedin
The confident path to treatment

Philips Radiation Oncology Solutions

Philips offers a proven portfolio of dedicated radiotherapy solutions that span diagnostic imaging to treatment planning. By integrating tools, systems, and software, we help you to improve patient care, accelerate time to treatment, enhance patient satisfaction, while maximizing the value of your investment.

Read more

Toward a model of personalized medicine

Cancer incidence and related healthcare costs continue to grow. There is a big need to diagnose and treat patients in efficient settings with a focus on the best care. The key? You must combine using the best imaging and therapy capabilities, patient experience and lowest cost with the goal to improve patient outcomes.

We help make this possible with tools and services for accurate first time right decision-making imaging, fast supporting right decision-making tools and enable targeted, patient-specific therapy. With Philips, the future of personalized oncology is within your reach.

Recent Trends

Rising threat

In 2008, cancer counted for 7.6 million deaths around the world. By 2030, this is projected to exceed 13.1 million.

Economic drain

Cancer has the most devastating economic impact of any cause of death worldwide - €662 billion in 2008 (not including direct costs of treating cancer). That’s 1.5% of global GDP.

Three imperatives to combat these trends

1. Confident diagnosis

Characterize or stage a patient’s disease accurately and completely, the first time. Enable multi-disciplinary collaboration.

2. Personalized therapies
Target patient-specific cancer using imaging‐based or integrated therapy. Improve long-term outcomes while minimizing side effects.

3. Efficient delivery

Optimize workflows to drive down cost of care and boost throughput, while improving patient experience. Provide enhanced Home Care.

Информация за контакт

* Това поле е задължително

Държава

Име*

Име (фонетичен)

Фамилия*

Фамилия (фонетичен)

Обръщение

Научно звание

Имейл адрес*

Телефон

Компания*

Длъжност

промишленост

Длъжност

специалност

Отдел

Щат / провинция

Град

Адрес

Пощенски код

Предишен

Като уточним причината Ви за връзка, ще можем да Ви предоставим по-добро обслужване.

Информация за проследяване

Предпочитан метод за контакт

Най-добро време за обаждане

Очаквано време за покупка

Коментиране

What is cross border data transfer?

I agree on cross-border transfer of personal information.

Предишен

Confident diagnosis

The challenge

Cancer care is moving towards optimal, personalized treatment choices that are tailored to individual patients. All of the information from disciplines in cancer diagnostics and genomics come together to inform the decisions made by cancer specialists during the diagnostic phase. Digitization of healthcare enables all diagnostic data (from radiology, pathology and in-vitro diagnostic tests) becoming available in a digital form.

At Philips, we enable characterization and staging a patient’s disease confidently.

The Philips Vereos PET/CT scanner with Digital Photon Counting will redefine PET imaging and mark a new era in clinical performance.

From routine studies to emerging applications, Ingenia’s dStream platform and advanced clinical solutions increase the imaging capabilities of MR to address major healthcare trends in oncology.

The IntelliSite Pathology solution is a highly scalable platform that enhances productivity with high-resolution digital images, collaboration features, and case management tools.

IntelliSpace Portal delivers easy clinical workflow and collaboration tools to help you streamline your daily routine. Unlock the power of CT, MR, Molecular imaging and ultrasound systems with oncology applications accessible wherever you are.

Lung cancer: Sharper images with profound increase in SUV and SNR for small lesion detection

Digital pathology: Uniting pathologists virtually to fight cancer

Ultrasound fusion: Changing the course of treatment

O-MAR Metal artifact reduction for more confident contouring

Personalized therapy

The challenge

The number of treatment options is continuously increasing. New targeted drugs are available and new minimally invasive approaches to focused therapies are required. Diagnostics and treatment need to become more integrated.

We at Philips enable patient-specific imaging and/or integrated therapy with the goal to enhance patient care.

Ingenia MR-RT meets specific RT needs by providing high-quality MR images acquired in the RT treatment position. Smoothly integrate MRI in your CT-based treatment planning workflow through a comprehensive solution that considers your whole workflow.

RTdrive for MR prostate combines multiple elements including the Ingenia MR-RT platform, MR-only simulation, Auto-Contouring and Pinnacle³ Auto-Planning, and allows you to generate high-quality treatment plans for prostate with fewer manual steps. Thanks to intelligent automation you can create plans within 25 minutes* with minimal user input, saving valuable time and effort.

Gain new clarity and risk management capabilities with OncoSuite* – the world’s first complete solution for embolization and ablation oncology procedures. This treatment environment can offer life-changing opportunities for your patients.

Philips Big Bore CT provides clinical excellence in radiation oncology, with a system design and workflow tailored to CT simulation. In addition, this big bore CT offers flexibility in performing radiology and interventional CT procedures as well.

Interventional oncology: Making the difference with Philips Live Image Guidance

Bone metastases: Effective treatment with MR-HIFU

Bringing the promise of proton therapy to more patients

MR-Linac: Game-changing technology

New ways to treat uterine fibroids

Intra-operative MR: Verifying tumor resection during neurosurgery

Efficient delivery

The challenge

There will be more cancer patients and rising care costs. The way to increase patient care while keeping control of cost is to make the process more efficient. The drive to provide more home care requires active monitoring.

We at Philips provide tools that enable a workflow that increases access to cancer care and drives down cost while also improving patient experience.

Fast, accurate, and interactive treatment planning tools have made Pinnacle³ a leader in radiation treatment planning. Pinnacle³ is the product of choice of many leading cancer centers globally.

Post-processing of oncology image datasets (CT, PET/CT, and MR) can pose a major challenge for radiology and oncology staff. Multi Modality Tumor Tracking applications provide the tools to simplify the review and analysis for tumor detection and monitoring.

Philips provides a robust portfolio of clinically rich, technologically sound healthcare informatics that connect people, technology, and data across the health continuum. Our intelligent, secure solutions help integrate systems, aggregate data, accelerate workflows, and inform decisions, giving clinical teams the insights they need to make possible what matters most‐‐healthier patients.